378 related articles for article (PubMed ID: 11709086)
21. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
22. The INPP4B paradox: Like PTEN, but different.
Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
[TBL] [Abstract][Full Text] [Related]
23. A PTEN-like phosphatase with a novel substrate specificity.
Pagliarini DJ; Worby CA; Dixon JE
J Biol Chem; 2004 Sep; 279(37):38590-6. PubMed ID: 15247229
[TBL] [Abstract][Full Text] [Related]
24. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
[TBL] [Abstract][Full Text] [Related]
25. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
[TBL] [Abstract][Full Text] [Related]
26. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
[TBL] [Abstract][Full Text] [Related]
27. Phosphatases as small-molecule targets: inhibiting the endogenous inhibitors of kinases.
Schmid AC; Woscholski R
Biochem Soc Trans; 2004 Apr; 32(Pt 2):348-9. PubMed ID: 15046606
[TBL] [Abstract][Full Text] [Related]
28. I-proteins - a proposed switch in myotubularin function.
Clague MJ; Dove SK; Barr FA
Trends Biochem Sci; 2004 Feb; 29(2):58-61. PubMed ID: 15102431
[TBL] [Abstract][Full Text] [Related]
29. A voltage-sensing phosphatase, Ci-VSP, which shares sequence identity with PTEN, dephosphorylates phosphatidylinositol 4,5-bisphosphate.
Iwasaki H; Murata Y; Kim Y; Hossain MI; Worby CA; Dixon JE; McCormack T; Sasaki T; Okamura Y
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):7970-5. PubMed ID: 18524949
[TBL] [Abstract][Full Text] [Related]
30. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover.
Maehama T; Okahara F; Kanaho Y
Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605
[TBL] [Abstract][Full Text] [Related]
31. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.
Backers K; Blero D; Paternotte N; Zhang J; Erneux C
Adv Enzyme Regul; 2003; 43():15-28. PubMed ID: 12791379
[No Abstract] [Full Text] [Related]
32. A novel class of PTEN protein in Arabidopsis displays unusual phosphoinositide phosphatase activity and efficiently binds phosphatidic acid.
Pribat A; Sormani R; Rousseau-Gueutin M; Julkowska MM; Testerink C; Joubès J; Castroviejo M; Laguerre M; Meyer C; Germain V; Rothan C
Biochem J; 2012 Jan; 441(1):161-71. PubMed ID: 21864294
[TBL] [Abstract][Full Text] [Related]
33. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
34. PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.
Kim S; Domon-Dell C; Wang Q; Chung DH; Di Cristofano A; Pandolfi PP; Freund JN; Evers BM
Gastroenterology; 2002 Oct; 123(4):1163-78. PubMed ID: 12360479
[TBL] [Abstract][Full Text] [Related]
35. PTEN M-CBR3, a versatile and selective regulator of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Evidence for Ins(1,3,4,5,6)P5 as a proliferative signal.
Orchiston EA; Bennett D; Leslie NR; Clarke RG; Winward L; Downes CP; Safrany ST
J Biol Chem; 2004 Jan; 279(2):1116-22. PubMed ID: 14561749
[TBL] [Abstract][Full Text] [Related]
36. Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial.
Seminario MC; Wange RL
Immunol Rev; 2003 Apr; 192():80-97. PubMed ID: 12670397
[TBL] [Abstract][Full Text] [Related]
37. Signaling pathways of D3-phosphoinositide-binding kinases in T cells and their regulation by PTEN.
Seminario MC; Wange RL
Semin Immunol; 2002 Feb; 14(1):27-36. PubMed ID: 11884228
[TBL] [Abstract][Full Text] [Related]
38. TPIP: a novel phosphoinositide 3-phosphatase.
Walker SM; Downes CP; Leslie NR
Biochem J; 2001 Dec; 360(Pt 2):277-83. PubMed ID: 11716755
[TBL] [Abstract][Full Text] [Related]
39. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
[TBL] [Abstract][Full Text] [Related]
40. Expanding coincident signaling by PTEN through its inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity.
Caffrey JJ; Darden T; Wenk MR; Shears SB
FEBS Lett; 2001 Jun; 499(1-2):6-10. PubMed ID: 11418101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
